Incheon, South Korea

Hye Young Kang

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hye Young Kang: Innovator in Pharmaceutical Formulations

Introduction

Hye Young Kang is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable liquid formulations for antibodies. With a total of three patents to his name, Kang's work is recognized for its innovative approaches to enhancing the stability and efficacy of pharmaceutical products.

Latest Patents

Kang's latest patents include a "Stable liquid formula comprising anti-TNFa antibody, acetate buffer, and glycine." This patent discloses a stable liquid formulation that includes an antibody or antigen-binding portion, an acetate buffer, glycine, and a surfactant. Notably, this formulation does not contain sugar, sugar alcohol, or metal salt, yet remains stable even with high antibody content, making it suitable for subcutaneous administration. Another significant patent is the "Stable liquid pharmaceutical preparation," which describes a formulation that includes an antibody or antigen-binding fragment, a surfactant, a sugar or sugar derivative, a buffer, and a stabilizer. This formulation is characterized by low viscosity and superior long-term storage stability, even under harsh conditions.

Career Highlights

Hye Young Kang is currently employed at Celltrion Inc., a leading biopharmaceutical company. His work at Celltrion focuses on developing innovative solutions for pharmaceutical formulations, contributing to the advancement of medical treatments.

Collaborations

Kang collaborates with talented colleagues, including Joon Won Lee and Yeon Kyeong Shin, who bring diverse expertise to their projects. Their teamwork enhances the innovative capacity of their research and development efforts.

Conclusion

Hye Young Kang's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the field. His patents reflect a deep understanding of the complexities involved in creating stable and effective medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…